Condition: Heart Failure with Preserved Ejection Fraction · Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine
With the cardiopulmonary exercise testing as the primary outcome, the study aims to evaluate the efficacy of Qishen Granules on cardiac function, quality of life and biomarker level of patients with heart failure with preserved ejection fraction (HFpEF), which will provide evidence for the treatment of HFpEF with traditional Chinese medicine.
This description comes directly from the study's public registry record.
Lei Wang, doctorate · 8620-81887233-3280 · Dr.wanglei@139.com
Always discuss trial participation with your own doctor first.
| Guangdong Provincial Hospital of Chinese Medicine | Guangzhou, Guangdong, China | Recruiting |
| WangLei | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06377761